tbuckley/cabot-search huggingface dataset:
Monodispersed Bioactive Glass Nanoclusters with Ultralarge Pores and Intrinsic Exceptionally High miRNA Loading for Efficiently Enhancing Bone Regeneration
Authors: Yumeng Xue, Yi Guo, Meng Yu, Min Wang, Peter X. Ma, Bo Lei
Journal: Advanced Healthcare Materials (2021)

Adv. Healthcare Mater. 2017, 6, 1700630 DOI: 10.1002/adhm.201700630 In the original version of this paper, the caption for Figure 4 did not mention that 4B was reproduced from another paper. The correct Figure 4 caption should be: Figure 4. Ultrahigh miRNA loading and protection capacity of BGNCs. Gel retardation pictures showing the miRNA binding ability of A) BGNCs and B) BGNs with different weight ratios to miRNA (2–64 mg µg−1). Reproduced with permission.[20] Copyright 2017, American Chemical Society. C) Quantitative miRNA loading efficiency of BGNC and BGN at 40 and 80 µg mL−1 (**p < 0.01, n = 5). D) Antinuclease degradation ability of various miRNA complexes after soaking in serum solution for 24 h. E) Quantitative miRNA intact percentage of different samples. Furthermore, the H-E/Masson images for BGN and BGNC in Figure 9 were produced incorrectly. The correct Figure 9 is shown below: The changes to Figure 9 do not affect the overall conclusions of this work. [20] M. Yu, Y. Xue, P. X. Ma, C. Mao, B. Lei, ACS Appl. Mater. Interfaces 2017, 9, 8460.
Correction: Characterization of the genotype and integration patterns of hepatitis B virus in early‐ and late‐onset hepatocellular carcinoma
Authors: Ling Zhang, Guannan Tang, Yuzhao Wang, Geng Xue, Shuhan Sun, Lulu Liu, Yongdong Dai, Jinna Chen, Tingting Zeng, Yan Li, Leilei Chen, Ying-Hui Zhu, Jiangchao Li, Stephanie Ma, Dan Xie, Yun-Fei Yuan, Xin-Yuan Guan
Journal: Hepatology (2016)
OFFICIAL NOTICE.
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Lesions of Peripheral Nerves: Erratum
Authors: T Nasmyth, R Maclellaad, W Cummins, J Rowtand Payne, Dora Allman, H Sylvester, War Ixeknon, E Watkins, F Rhodes, Charlesj Evers, G Frdrogers, J Laing
Journal: BMJ (1918)

XAY 4, X9X8 was he who, without visual examination, tried to assure her that the test would give the orrect anawr.I was only asked by a colleague to give the injection, and wvhen I visited her she was in the secondary stage.The question of my ability need; not necessarily have arisen, for all the cases had been previously diagnoset, except one, which others had mised.Had the diagnosis not been definite, I do not think I should have wished Io a Wasermann test, for even Profesor Beattie is not prepared to say that the test is iEaThible.He says it aids.It aids also to mnake an indefinite diagnosis more indefinite by its indefinitenes.
Outwitting Your Years
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Thomas Cadwalader (1708-1779)
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hydroxyprolinemia Associated with Mental Deficiency
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Obituary
Authors: Ralph Crawshaw
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Tumor Immunity
Authors: R. R. Spencer
Journal: JNCI Journal of the National Cancer Institute (1942)

Journal Article Tumor Immunity Get access R. R. Spencer R. R. Spencer assistant chief National Cancer Institute, National Institute of Health, United States Public Health Service Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 2, Issue 4, February 1942, Pages 317–332, https://doi.org/10.1093/jnci/2.4.317 Published: 01 February 1942
Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial
Authors: J. Souglakos, N. Ziras, A. Polyzos, A. Athanasiadis, S. Kakolyris, T. Giannakakis, E. Tselepatiotis, K. Kalbakis, N. Vardakis, V. Georgoulias
Journal: Journal of Clinical Oncology (2004)

3532 Background: In a phase II trial conducted from our group the 4-drug regimen (5FU+LV+CPT-11+L-OHP) was highly active and well tolerated (JCO 2002;20:2661–2667). A randomized trial was conducted to compare in terms of overall survival (OS) the 4-drug regimen (Arm-A) with the "standard" 3-drug (5FU+LV+CPT-11) FOLFIRI regimen (Arm-B) as first-line treatment in MCC Methods: Assuming OS 17months for Arm-B and 21 months for Arm-A, 276 pts were needed to show a significant difference (two-tailed log-rank test; a=0.05, b=0.8). For Arm-A CPT-11 150mg/m2 30–90 min infusion was given on d1, L-OHP 65mg/m2 2h infusion on d2, simultaneously but in different lines with LV 200mg/m2 on days 2+3 followed by 5-FU 400 mg/m2/d iv bolus and 600 mg/m2/d 22h infusion on days 2+3. For Arm-B CPT-11 180mg/m2 30–90 min infusion was given on d1, LV 200 mg/m2 on days 1+2 followed by 5-FU 400 mg/m2/d iv bolus and 600 mg/m2/d 22h infusion on days 1+2. Cycles were repeated every 2 weeks until disease progression, unacceptable toxicity or consent withdrawal. Results: As of today 203 pts and 1673 cy of therapy were evaluable for safety and efficacy. 101 pts on Arm-A: M/F: 62/39, PS 0/1/2: 59/30/12, median age 65 (25–75).102 pts on Arm-B: M/F: 57/45, PS 0/1/2: 47/39/16, median age 66 (42–80). In an intention-to-treat analysis the response rate was 45% (95%CI 35,45%–55,27%) in Arm-A and 31% (95%CI 22,68%–41,24%) in Arm-B (p=0,055). In addition 32% of pts presented stable disease in Arm-A and 23% in Arm-B (p=0,147). Disease progression was observed in 23% of pts in Arm-A and 45% in Arm-B(p=0,001). Median TTP was 8.9 and 6.1 months (p=0,0958) and OS 21.1 and 16.5 months in Arm-A and Arm-B, respectively (Log rank=0,0956). Conclusions: These preliminary results show promising efficacy with acceptable safety for the 4-drug combination. Updated data will be presented. No significant financial relationships to disclose.
Vaccinial Encephalitis
Authors: E. Sakoschansky, H. J. Trenchard
Journal: BMJ (1939)

MEDICAL JOURNALof headache and nausea only were observed.All the cases of rash and temperature occurred with the larger doses.In view of the suggestions and observations with regard to the delayed method of treatment, I have extracted my findings on seventy-three cases with the same dosagenamely, one tablet four times a day.I have followed the method adopted by Cokkinis and McElligott, and although my numbers are small they at least give some guidance.From Table III it is evident that there is no material difference between early and late treatment.TABLE III Duration of Disease No. of G.C.-neg.Dry before Treatment (Days) Cases (Days) (Days) 1-3 .211.9 4.65 4-5 .43.25 6.5 6-7.17 1.63 5.
Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia
Authors: Vicki Babulas
Journal: American Journal of Psychiatry (2006)

Objective: In this birth cohort study, the authors examined the relation between prenatal exposure to maternal genital/reproductive (G/R) infections and schizophrenia in offspring. Method: The birth cohort consisted of 7,794 offspring of pregnancies with prospectively acquired data on maternal G/R infections from obstetric records. The authors diagnosed 71 cases of schizophrenia and other schizophrenia spectrum disorders in this cohort. The relationship between maternal G/R infections and schizophrenia risk was modeled. Results: Exposure to G/R infections during the periconceptional period was associated with a significantly increased risk of schizophrenia and other schizophrenia spectrum disorders, with adjustment for maternal race, education, age, and mental illness. Conclusions: Maternal G/R infection during periconception appears to increase the risk of schizophrenia in offspring.
DRAMA IN STATISTICS
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hematology
Authors: Elmer B. Brown
Journal: JAMA (1972)

Williams, Beutler, Erslev, and Rundles, editors of<i>Hematology</i>, state in the preface that "the purpose of this book is to provide clinicians, in practice or in training, investigators, and students with a ready source of detailed information regarding the whole of hematology as it applies to man, with emphasis on the biochemical and physiologic approach to this field." In general, they have achieved their goal and have compiled a volume that provides a new standard for encyclopedic hematology texts. The vast amount of information in this book is presented in 169 short chapters that make topics easy to find. The book is divided into five major parts, namely: the erythrocyte, the leukocytes, hemostasis, and replacement therapy, with an introductory part devoted to the clinical evaluation of the patient with hematologic disease. An appendix provides a convenient description of common laboratory techniques. Technically, the type and double-column format is easy to
New Books
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE POSSIBILITIES OF THE MEDICAL DEPARTMENT OF AN ARMY.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Typhoid Fever: Pathogenesis and Immunologic Control
Authors: R. B. Hornick, S. E. Greisman, T. E. Woodward, H. L. DuPont, A. T. Hawkins, M. J. Snyder
Journal: New England Journal of Medicine (1970)

Contribution of Bacterial EndotoxinEndotoxin is obviously an important component of any gram-negative rod such as the typhoid bacillus. Vi antigen appears important in enhancing human virulence of typhoid strains. It is not as simple to define the importance of endotoxin since this substance has many biologic and pharmacologic activities. Attempts were made in the course of these investigations to gather information on the role of purified endotoxin in the pathogenesis of typhoid fever by quantitating the response to endotoxin's pyrogenic activity in volunteers with and without typhoid fever.When 0.25 µg of a purified endotoxin from S. typhosa was . . .
Cost-effectiveness analysis of elective neck dissection in patients with clinically node negative oral cavity cancer.
Authors: Joseph Roy Acevedo, Katherine Elaine Fero, Bayard R Wilson, Charles Coffey, James Don Murphy
Journal: Journal of Clinical Oncology (2016)

e18275 Background: Recently, a large randomized controlled trial found a survival advantage among patients who received an elective neck dissection after primary surgery for clinically node negative oral cavity cancer compared to those receiving primary surgery alone. Here, we performed a cost-effectiveness analysis to determine the value of adding an elective neck dissection to the surgical management of early stage oral cavity cancer. Methods: We constructed a Markov model to simulate survival and recurrence in patients with T1/T2 clinically node negative oral cavity squamous cell carcinoma. Transition probabilities were derived from randomized clinical trial data; cost (2015 US dollars) and health utilities were estimated from the literature. Cost-effectiveness was measured with incremental cost-effectiveness ratios (ICERs) expressed as dollar per quality-adjusted life-year (QALY), with ICERs less than $50,000/QALY considered a cost-effective treatment strategy. We conducted one-way and probabilistic sensitivity analyses with Monte-Carlo simulations to examine model uncertainty. Results: Our base-case model found that the addition of an elective neck dissection to primary surgery reduced overall costs by $6,000, and improved patient outcomes by 0.41 QALY compared to primary surgery alone. The decrease in cost despite the added elective neck dissection was due to lower use of chemotherapy, radiation, and salvage surgery. On one-way sensitivity analysis the model was most sensitive to assumptions about disease progression and survival among those receiving an elective neck dissection. Additionally, the model was mildly sensitive to the health utility reduction from a neck dissection. Probabilistic sensitivity analysis found that treatment with an elective neck dissection was a cost-effective option 84% of the time at a willingness to pay threshold of $50,000/QALY. Conclusions: Our study demonstrates that the addition of an elective neck dissection reduces costs and improves health outcomes, making this a cost-effective treatment option among patients with early-stage oral cavity cancer.
Analysis of Risk Factors Influencing Outcomes After Unrelated Cord Blood Transplantation In Children with Juvenile Myelomonocytic Leukemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study
Authors: Alessandro Crotta, Vanderson Rocha, Mary Eapen, John E. Wagner, Margaret L. MacMillan, Marco Zecca, Joanne Kurtzberg, Carmen Bonfim, Ajay J. Vora, Cristina Díaz de Heredia, Mohamad Mohty, Lochie Teague, Jerry Stein, Tracey A. O'Brien, Henrique Bittencourt, Adrienne B.M. Madureira, Christina Peters, Charlotte Marie Niemeyer, Eliane Gluckman, Franco Locatelli
Journal: Blood (2010)
Predictors of Lack of Improvement After Thrombolytic Stroke Therapy—Reply
Authors: Gustavo Saposnik, Bryan Young, Vladimir Hachinski
Journal: JAMA (2005)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal